A highly consistent expression pattern of IDO was observed in the primary tumor, the sentinel lymph node and metastatic tissues of melanoma patients, indicating that immune suppression is determined very early in the disease course of these patients [8]. The gene discussed is IDO1; the disease is melanoma.